<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-566BYMJ9</identifier><date>2016</date><creator>Pascale, Mariarosa</creator><relation>documents/doc/5/URN_NBN_SI_doc-566BYMJ9_001.pdf</relation><relation>documents/doc/5/URN_NBN_SI_doc-566BYMJ9_001.txt</relation><format format_type="issue">3</format><format format_type="volume">50</format><format format_type="type">article</format><format format_type="extent">str. 313-320, V</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">288224768</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-566BYMJ9</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">prognoza</subject><subject language_type_id="slv">prostata</subject><subject language_type_id="eng">prostate</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">tumorski označevalci</subject><title>The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients</title></Record>